Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/38926
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNasreddine, R.-
dc.contributor.authorFlorence, E.-
dc.contributor.authorYombi, J.-
dc.contributor.authorHenrard, S.-
dc.contributor.authorDarcis, G.-
dc.contributor.authorVan Praet, J.-
dc.contributor.authorVandekerckhove, L.-
dc.contributor.authorAllard, S.-
dc.contributor.authorDemeester, R.-
dc.contributor.authorMESSIAEN, Peter-
dc.contributor.authorAusselet, N.-
dc.contributor.authorDelforge, M.-
dc.contributor.authorDe Wit, S.-
dc.date.accessioned2022-11-28T08:00:09Z-
dc.date.available2022-11-28T08:00:09Z-
dc.date.issued2022-
dc.date.submitted2022-11-18T12:39:38Z-
dc.identifier.citationJournal of the International AIDS Society, 25 , p. 116 -117-
dc.identifier.issn-
dc.identifier.urihttp://hdl.handle.net/1942/38926-
dc.description.abstractConclusion • Several RCTs have demonstrated BIC/FTC/TAF to be a first-line option for treatment-naïve and experienced PLWH [1-4]. • Real-world studies provide complementary information to RCTs and ensure that those results can be generalized to broader populations seen in daily practice. • The aim of this study was to describe the Belgian HIV population treated with BIC/FTC/TAF and to evaluate its efficacy, durability, and tolerability in a real-world setting.-
dc.description.sponsorshipWe would like to thank everyone who contributed to this study including the study participants and investigators. This study was supported by a grant from Gilead International.-
dc.language.isoen-
dc.publisherJOHN WILEY & SONS LTD-
dc.titleA retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium-
dc.typeJournal Contribution-
dc.identifier.epage117-
dc.identifier.spage116-
dc.identifier.volume25-
local.format.pages2-
local.bibliographicCitation.jcatM-
local.publisher.placeTHE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrP122-
dc.identifier.isi000870695800142-
local.provider.typewosris-
local.description.affiliation[Nasreddine, R.; Delforge, M.; De Wit, S.] St Pierre Univ Hosp, Div Infect Dis, Brussels, Belgium.-
local.description.affiliation[Florence, E.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.-
local.description.affiliation[Yombi, J.] Clin Univ St Luc, Div Infect Dis, Brussels, Belgium.-
local.description.affiliation[Henrard, S.] Erasme Univ Hosp, Univ Clin Brussels, Dept Internal Med, Brussels, Belgium.-
local.description.affiliation[Darcis, G.] Liege Univ Hosp, Dept Infect Dis & Gen Internal Med, Liege, Belgium.-
local.description.affiliation[Van Praet, J.] AZ Sint Jan Brugge Oostende, Dept Nephrol & Infect Dis, Brugge, Belgium.-
local.description.affiliation[Vandekerckhove, L.] Ghent Univ Hosp, Dept Internal Med, Ghent, Belgium.-
local.description.affiliation[Allard, S.] Univ Ziekenhuis Brussel, Dept Internal Med & Infect Dis, Brussels, Belgium.-
local.description.affiliation[Demeester, R.] Univ Hosp Charleroi, Dept Internal Med, Lodelinsart, Belgium.-
local.description.affiliation[Messiaen, P.] Jessa Hosp, Dept Infect Dis & Immun, Hasselt, Belgium.-
local.description.affiliation[Ausselet, N.] UCL Univ Hosp Namur Godinne, Dept Infect Dis, Yvoir, Belgium.-
local.uhasselt.internationalno-
item.fullcitationNasreddine, R.; Florence, E.; Yombi, J.; Henrard, S.; Darcis, G.; Van Praet, J.; Vandekerckhove, L.; Allard, S.; Demeester, R.; MESSIAEN, Peter; Ausselet, N.; Delforge, M. & De Wit, S. (2022) A retrospective, multicentre study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium. In: Journal of the International AIDS Society, 25 , p. 116 -117.-
item.contributorNasreddine, R.-
item.contributorFlorence, E.-
item.contributorYombi, J.-
item.contributorHenrard, S.-
item.contributorDarcis, G.-
item.contributorVan Praet, J.-
item.contributorVandekerckhove, L.-
item.contributorAllard, S.-
item.contributorDemeester, R.-
item.contributorMESSIAEN, Peter-
item.contributorAusselet, N.-
item.contributorDelforge, M.-
item.contributorDe Wit, S.-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
crisitem.journal.issn1758-2652-
crisitem.journal.eissn1758-2652-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
HIV Glasgow.pdf
  Restricted Access		Published version64.8 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.